nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—Pigmentation skin—Prednisone—Crohn's disease	0.0394	0.042	CcSEcCtD
Prochlorperazine—Cholestasis—Mercaptopurine—Crohn's disease	0.033	0.0352	CcSEcCtD
Prochlorperazine—Liver injury—Mercaptopurine—Crohn's disease	0.0298	0.0317	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Mercaptopurine—Crohn's disease	0.0251	0.0267	CcSEcCtD
Prochlorperazine—Systemic lupus erythematosus—Mesalazine—Crohn's disease	0.0246	0.0262	CcSEcCtD
Prochlorperazine—Pigmentation disorder—Prednisone—Crohn's disease	0.0216	0.023	CcSEcCtD
Prochlorperazine—Cholestasis—Azathioprine—Crohn's disease	0.0197	0.021	CcSEcCtD
Prochlorperazine—Throat sore—Mesalazine—Crohn's disease	0.0189	0.0201	CcSEcCtD
Prochlorperazine—Oropharyngeal discomfort—Mesalazine—Crohn's disease	0.0187	0.0199	CcSEcCtD
Prochlorperazine—Cholestasis—Mesalazine—Crohn's disease	0.0179	0.0191	CcSEcCtD
Prochlorperazine—Liver injury—Azathioprine—Crohn's disease	0.0178	0.0189	CcSEcCtD
Prochlorperazine—Jaundice cholestatic—Azathioprine—Crohn's disease	0.017	0.0181	CcSEcCtD
Prochlorperazine—Blood disorder—Mesalazine—Crohn's disease	0.0163	0.0174	CcSEcCtD
Prochlorperazine—Liver injury—Mesalazine—Crohn's disease	0.0162	0.0172	CcSEcCtD
Prochlorperazine—Jaundice cholestatic—Mesalazine—Crohn's disease	0.0155	0.0165	CcSEcCtD
Prochlorperazine—Amenorrhoea—Mesalazine—Crohn's disease	0.0155	0.0165	CcSEcCtD
Prochlorperazine—Oropharyngeal pain—Mesalazine—Crohn's disease	0.015	0.0159	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Azathioprine—Crohn's disease	0.0149	0.0159	CcSEcCtD
Prochlorperazine—Pancytopenia—Mercaptopurine—Crohn's disease	0.0149	0.0159	CcSEcCtD
Prochlorperazine—Embolism venous—Prednisone—Crohn's disease	0.0143	0.0152	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Azathioprine—Crohn's disease	0.014	0.0149	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Mesalazine—Crohn's disease	0.0136	0.0145	CcSEcCtD
Prochlorperazine—Menstruation irregular—Prednisone—Crohn's disease	0.013	0.0138	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Mesalazine—Crohn's disease	0.0128	0.0136	CcSEcCtD
Prochlorperazine—Coma—Mesalazine—Crohn's disease	0.0124	0.0132	CcSEcCtD
Prochlorperazine—Photosensitivity—Mesalazine—Crohn's disease	0.0112	0.012	CcSEcCtD
Prochlorperazine—Eczema—Mesalazine—Crohn's disease	0.011	0.0117	CcSEcCtD
Prochlorperazine—Increased appetite—Mesalazine—Crohn's disease	0.0105	0.0112	CcSEcCtD
Prochlorperazine—Leukopenia—Mercaptopurine—Crohn's disease	0.00981	0.0104	CcSEcCtD
Prochlorperazine—Oedema—Mercaptopurine—Crohn's disease	0.00895	0.00953	CcSEcCtD
Prochlorperazine—Pancytopenia—Azathioprine—Crohn's disease	0.0089	0.00948	CcSEcCtD
Prochlorperazine—Glycosuria—Prednisone—Crohn's disease	0.00889	0.00946	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00876	0.00933	CcSEcCtD
Prochlorperazine—Skin disorder—Mercaptopurine—Crohn's disease	0.00869	0.00925	CcSEcCtD
Prochlorperazine—Dysphagia—Mesalazine—Crohn's disease	0.00854	0.00909	CcSEcCtD
Prochlorperazine—Asthma—Mesalazine—Crohn's disease	0.00854	0.00909	CcSEcCtD
Prochlorperazine—Influenza—Mesalazine—Crohn's disease	0.00854	0.00909	CcSEcCtD
Prochlorperazine—Eosinophilia—Mesalazine—Crohn's disease	0.00845	0.009	CcSEcCtD
Prochlorperazine—Amenorrhoea—Prednisone—Crohn's disease	0.00819	0.00873	CcSEcCtD
Prochlorperazine—Pancytopenia—Mesalazine—Crohn's disease	0.00811	0.00863	CcSEcCtD
Prochlorperazine—Agranulocytosis—Azathioprine—Crohn's disease	0.0078	0.00831	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00779	0.0083	CcSEcCtD
Prochlorperazine—Weight increased—Mesalazine—Crohn's disease	0.00777	0.00827	CcSEcCtD
Prochlorperazine—Jaundice—Mesalazine—Crohn's disease	0.00742	0.0079	CcSEcCtD
Prochlorperazine—Agranulocytosis—Mesalazine—Crohn's disease	0.0071	0.00757	CcSEcCtD
Prochlorperazine—Erythema multiforme—Azathioprine—Crohn's disease	0.00709	0.00755	CcSEcCtD
Prochlorperazine—Body temperature increased—Mercaptopurine—Crohn's disease	0.00707	0.00753	CcSEcCtD
Prochlorperazine—Oedema peripheral—Mesalazine—Crohn's disease	0.00673	0.00717	CcSEcCtD
Prochlorperazine—Arrhythmia—Azathioprine—Crohn's disease	0.0067	0.00714	CcSEcCtD
Prochlorperazine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00659	0.00702	CcSEcCtD
Prochlorperazine—Erythema multiforme—Mesalazine—Crohn's disease	0.00646	0.00688	CcSEcCtD
Prochlorperazine—Erythema—Mesalazine—Crohn's disease	0.00595	0.00634	CcSEcCtD
Prochlorperazine—Leukopenia—Azathioprine—Crohn's disease	0.00585	0.00623	CcSEcCtD
Prochlorperazine—Nervousness—Mesalazine—Crohn's disease	0.00578	0.00615	CcSEcCtD
Prochlorperazine—Muscle spasms—Mesalazine—Crohn's disease	0.00572	0.00609	CcSEcCtD
Prochlorperazine—Rash—Mercaptopurine—Crohn's disease	0.00564	0.00601	CcSEcCtD
Prochlorperazine—Dermatitis—Mercaptopurine—Crohn's disease	0.00563	0.006	CcSEcCtD
Prochlorperazine—Vision blurred—Mesalazine—Crohn's disease	0.00561	0.00597	CcSEcCtD
Prochlorperazine—Desipramine—SLC22A4—Crohn's disease	0.0056	0.229	CrCbGaD
Prochlorperazine—Tremor—Mesalazine—Crohn's disease	0.00557	0.00594	CcSEcCtD
Prochlorperazine—Increased appetite—Prednisone—Crohn's disease	0.00556	0.00592	CcSEcCtD
Prochlorperazine—Angioedema—Mesalazine—Crohn's disease	0.00544	0.00579	CcSEcCtD
Prochlorperazine—Leukopenia—Mesalazine—Crohn's disease	0.00532	0.00567	CcSEcCtD
Prochlorperazine—Infection—Azathioprine—Crohn's disease	0.00529	0.00564	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Azathioprine—Crohn's disease	0.00522	0.00556	CcSEcCtD
Prochlorperazine—Cough—Mesalazine—Crohn's disease	0.00519	0.00553	CcSEcCtD
Prochlorperazine—Skin disorder—Azathioprine—Crohn's disease	0.00518	0.00551	CcSEcCtD
Prochlorperazine—Hypotension—Azathioprine—Crohn's disease	0.00498	0.0053	CcSEcCtD
Prochlorperazine—Cardiac arrest—Prednisone—Crohn's disease	0.00497	0.00529	CcSEcCtD
Prochlorperazine—Dry mouth—Mesalazine—Crohn's disease	0.00495	0.00527	CcSEcCtD
Prochlorperazine—Oedema—Mesalazine—Crohn's disease	0.00485	0.00517	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Mesalazine—Crohn's disease	0.00485	0.00517	CcSEcCtD
Prochlorperazine—Infection—Mesalazine—Crohn's disease	0.00482	0.00514	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Mesalazine—Crohn's disease	0.00475	0.00506	CcSEcCtD
Prochlorperazine—Imipramine—SLC22A4—Crohn's disease	0.00475	0.194	CrCbGaD
Prochlorperazine—Skin disorder—Mesalazine—Crohn's disease	0.00472	0.00502	CcSEcCtD
Prochlorperazine—Hypotension—Mesalazine—Crohn's disease	0.00454	0.00483	CcSEcCtD
Prochlorperazine—Insomnia—Mesalazine—Crohn's disease	0.00439	0.00468	CcSEcCtD
Prochlorperazine—Dyspnoea—Mesalazine—Crohn's disease	0.00433	0.00461	CcSEcCtD
Prochlorperazine—Somnolence—Mesalazine—Crohn's disease	0.00432	0.0046	CcSEcCtD
Prochlorperazine—Body temperature increased—Azathioprine—Crohn's disease	0.00421	0.00449	CcSEcCtD
Prochlorperazine—Desipramine—SLC22A5—Crohn's disease	0.00421	0.172	CrCbGaD
Prochlorperazine—Erectile dysfunction—Prednisone—Crohn's disease	0.00416	0.00443	CcSEcCtD
Prochlorperazine—Constipation—Mesalazine—Crohn's disease	0.00415	0.00442	CcSEcCtD
Prochlorperazine—Weight increased—Prednisone—Crohn's disease	0.00411	0.00438	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Prednisone—Crohn's disease	0.00407	0.00434	CcSEcCtD
Prochlorperazine—Hypersensitivity—Azathioprine—Crohn's disease	0.00393	0.00418	CcSEcCtD
Prochlorperazine—Urticaria—Mesalazine—Crohn's disease	0.00386	0.00411	CcSEcCtD
Prochlorperazine—Body temperature increased—Mesalazine—Crohn's disease	0.00384	0.00409	CcSEcCtD
Prochlorperazine—Hypersensitivity—Mesalazine—Crohn's disease	0.00358	0.00381	CcSEcCtD
Prochlorperazine—Dizziness—Azathioprine—Crohn's disease	0.00352	0.00375	CcSEcCtD
Prochlorperazine—Pruritus—Mesalazine—Crohn's disease	0.00343	0.00366	CcSEcCtD
Prochlorperazine—Rash—Azathioprine—Crohn's disease	0.00336	0.00358	CcSEcCtD
Prochlorperazine—Dermatitis—Azathioprine—Crohn's disease	0.00336	0.00358	CcSEcCtD
Prochlorperazine—Headache—Azathioprine—Crohn's disease	0.00334	0.00356	CcSEcCtD
Prochlorperazine—Arrhythmia—Prednisone—Crohn's disease	0.00323	0.00344	CcSEcCtD
Prochlorperazine—Dizziness—Mesalazine—Crohn's disease	0.00321	0.00342	CcSEcCtD
Prochlorperazine—Erythema—Prednisone—Crohn's disease	0.00315	0.00335	CcSEcCtD
Prochlorperazine—Rash—Mesalazine—Crohn's disease	0.00306	0.00326	CcSEcCtD
Prochlorperazine—Dermatitis—Mesalazine—Crohn's disease	0.00306	0.00326	CcSEcCtD
Prochlorperazine—Headache—Mesalazine—Crohn's disease	0.00304	0.00324	CcSEcCtD
Prochlorperazine—Vision blurred—Prednisone—Crohn's disease	0.00297	0.00316	CcSEcCtD
Prochlorperazine—Agitation—Prednisone—Crohn's disease	0.00289	0.00308	CcSEcCtD
Prochlorperazine—Angioedema—Prednisone—Crohn's disease	0.00288	0.00306	CcSEcCtD
Prochlorperazine—Convulsion—Prednisone—Crohn's disease	0.00273	0.0029	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Prednisone—Crohn's disease	0.00257	0.00274	CcSEcCtD
Prochlorperazine—Oedema—Prednisone—Crohn's disease	0.00257	0.00274	CcSEcCtD
Prochlorperazine—Infection—Prednisone—Crohn's disease	0.00255	0.00272	CcSEcCtD
Prochlorperazine—Skin disorder—Prednisone—Crohn's disease	0.00249	0.00266	CcSEcCtD
Prochlorperazine—Insomnia—Prednisone—Crohn's disease	0.00232	0.00247	CcSEcCtD
Prochlorperazine—Constipation—Prednisone—Crohn's disease	0.0022	0.00234	CcSEcCtD
Prochlorperazine—Urticaria—Prednisone—Crohn's disease	0.00204	0.00217	CcSEcCtD
Prochlorperazine—Body temperature increased—Prednisone—Crohn's disease	0.00203	0.00216	CcSEcCtD
Prochlorperazine—Acepromazine—ALB—Crohn's disease	0.00191	0.0781	CrCbGaD
Prochlorperazine—Hypersensitivity—Prednisone—Crohn's disease	0.00189	0.00202	CcSEcCtD
Prochlorperazine—Thioproperazine—ALB—Crohn's disease	0.00187	0.0763	CrCbGaD
Prochlorperazine—Pipotiazine—ALB—Crohn's disease	0.00184	0.0751	CrCbGaD
Prochlorperazine—Thiothixene—ALB—Crohn's disease	0.00184	0.0751	CrCbGaD
Prochlorperazine—Pruritus—Prednisone—Crohn's disease	0.00182	0.00194	CcSEcCtD
Prochlorperazine—Dizziness—Prednisone—Crohn's disease	0.0017	0.00181	CcSEcCtD
Prochlorperazine—Rash—Prednisone—Crohn's disease	0.00162	0.00172	CcSEcCtD
Prochlorperazine—Dermatitis—Prednisone—Crohn's disease	0.00162	0.00172	CcSEcCtD
Prochlorperazine—Headache—Prednisone—Crohn's disease	0.00161	0.00171	CcSEcCtD
Prochlorperazine—Clomipramine—ALB—Crohn's disease	0.00145	0.0594	CrCbGaD
Prochlorperazine—Chlorpromazine—ALB—Crohn's disease	0.000996	0.0407	CrCbGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—CCR9—Crohn's disease	9.52e-05	0.0026	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—CCR6—Crohn's disease	9.51e-05	0.0026	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—GPR65—Crohn's disease	9.27e-05	0.00253	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—ACKR2—Crohn's disease	8.96e-05	0.00245	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—GPR65—Crohn's disease	8.85e-05	0.00242	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—PTGER4—Crohn's disease	8.67e-05	0.00237	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—CCR9—Crohn's disease	8.64e-05	0.00236	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—PTGER4—Crohn's disease	8.51e-05	0.00233	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MLN—Crohn's disease	8.5e-05	0.00232	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—CCR9—Crohn's disease	8.4e-05	0.0023	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—PTGER4—Crohn's disease	8.37e-05	0.00229	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—CCR9—Crohn's disease	8.25e-05	0.00225	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—CCR9—Crohn's disease	8.11e-05	0.00222	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—GPR65—Crohn's disease	8.03e-05	0.0022	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—GPR65—Crohn's disease	7.81e-05	0.00213	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—ACKR2—Crohn's disease	7.77e-05	0.00212	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—TAGAP—Crohn's disease	7.77e-05	0.00212	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—GPR65—Crohn's disease	7.67e-05	0.0021	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—CCR9—Crohn's disease	7.63e-05	0.00208	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—GPR65—Crohn's disease	7.54e-05	0.00206	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—CCR9—Crohn's disease	7.49e-05	0.00205	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—CCR9—Crohn's disease	7.37e-05	0.00201	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MLN—Crohn's disease	7.37e-05	0.00201	CbGpPWpGaD
Prochlorperazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	7.32e-05	0.002	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—CCR6—Crohn's disease	7.27e-05	0.00199	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—GPR65—Crohn's disease	7.09e-05	0.00194	CbGpPWpGaD
Prochlorperazine—CHRM2—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	7.03e-05	0.00192	CbGpPWpGaD
Prochlorperazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	6.99e-05	0.00191	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—GPR65—Crohn's disease	6.96e-05	0.0019	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—ACKR2—Crohn's disease	6.86e-05	0.00187	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—GPR65—Crohn's disease	6.85e-05	0.00187	CbGpPWpGaD
Prochlorperazine—DRD3—G alpha (i) signalling events—CXCL8—Crohn's disease	6.85e-05	0.00187	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—RSPO3—Crohn's disease	6.79e-05	0.00186	CbGpPWpGaD
Prochlorperazine—CHRM2—SIDS Susceptibility Pathways—IL1B—Crohn's disease	6.74e-05	0.00184	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TAGAP—Crohn's disease	6.74e-05	0.00184	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—ACKR2—Crohn's disease	6.73e-05	0.00184	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—ACKR2—Crohn's disease	6.62e-05	0.00181	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—CCR6—Crohn's disease	6.6e-05	0.0018	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MLN—Crohn's disease	6.5e-05	0.00178	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—SEL1L—Crohn's disease	6.44e-05	0.00176	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—PTGER4—Crohn's disease	6.4e-05	0.00175	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MLN—Crohn's disease	6.38e-05	0.00174	CbGpPWpGaD
Prochlorperazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	6.34e-05	0.00173	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—CCR6—Crohn's disease	6.3e-05	0.00172	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MLN—Crohn's disease	6.28e-05	0.00172	CbGpPWpGaD
Prochlorperazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	6.05e-05	0.00165	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TAGAP—Crohn's disease	5.95e-05	0.00162	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CCR9—Crohn's disease	5.89e-05	0.00161	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—RSPO3—Crohn's disease	5.89e-05	0.00161	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TAGAP—Crohn's disease	5.84e-05	0.0016	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—PTGER4—Crohn's disease	5.81e-05	0.00159	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TAGAP—Crohn's disease	5.74e-05	0.00157	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—CCR6—Crohn's disease	5.72e-05	0.00156	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—SEL1L—Crohn's disease	5.58e-05	0.00153	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—CCR6—Crohn's disease	5.56e-05	0.00152	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—PTGER4—Crohn's disease	5.55e-05	0.00152	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—GPR65—Crohn's disease	5.47e-05	0.0015	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—CCR6—Crohn's disease	5.46e-05	0.00149	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—IL3—Crohn's disease	5.45e-05	0.00149	CbGpPWpGaD
Prochlorperazine—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	5.44e-05	0.00149	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—CCR6—Crohn's disease	5.38e-05	0.00147	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—RASGRP1—Crohn's disease	5.27e-05	0.00144	CbGpPWpGaD
Prochlorperazine—DRD2—G alpha (i) signalling events—CXCL8—Crohn's disease	5.24e-05	0.00143	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—RSPO3—Crohn's disease	5.2e-05	0.00142	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CCR9—Crohn's disease	5.11e-05	0.0014	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—RSPO3—Crohn's disease	5.1e-05	0.00139	CbGpPWpGaD
Prochlorperazine—CHRM2—G alpha (i) signalling events—CXCL8—Crohn's disease	5.06e-05	0.00138	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—CCR6—Crohn's disease	5.05e-05	0.00138	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—PTGER4—Crohn's disease	5.04e-05	0.00138	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—RSPO3—Crohn's disease	5.02e-05	0.00137	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—CCR6—Crohn's disease	4.96e-05	0.00136	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—IL3—Crohn's disease	4.95e-05	0.00135	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—SEL1L—Crohn's disease	4.93e-05	0.00135	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—PTGER4—Crohn's disease	4.9e-05	0.00134	CbGpPWpGaD
Prochlorperazine—CHRM2—SIDS Susceptibility Pathways—TNF—Crohn's disease	4.89e-05	0.00134	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—CCR6—Crohn's disease	4.88e-05	0.00133	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—SEL1L—Crohn's disease	4.84e-05	0.00132	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—PTGER4—Crohn's disease	4.81e-05	0.00131	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—RASGRP1—Crohn's disease	4.79e-05	0.00131	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—SEL1L—Crohn's disease	4.76e-05	0.0013	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—GPR65—Crohn's disease	4.75e-05	0.0013	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—PTGER4—Crohn's disease	4.73e-05	0.00129	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—IL3—Crohn's disease	4.73e-05	0.00129	CbGpPWpGaD
Prochlorperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	4.72e-05	0.00129	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—RASGRP1—Crohn's disease	4.57e-05	0.00125	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CCR9—Crohn's disease	4.51e-05	0.00123	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—PTGER4—Crohn's disease	4.45e-05	0.00122	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CCR9—Crohn's disease	4.42e-05	0.00121	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—PTGER4—Crohn's disease	4.37e-05	0.00119	CbGpPWpGaD
Prochlorperazine—DRD3—Circadian rythm related genes—IL6—Crohn's disease	4.36e-05	0.00119	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CCR9—Crohn's disease	4.35e-05	0.00119	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—PTGER4—Crohn's disease	4.3e-05	0.00117	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—IL3—Crohn's disease	4.29e-05	0.00117	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—GPR65—Crohn's disease	4.19e-05	0.00114	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—IL3—Crohn's disease	4.17e-05	0.00114	CbGpPWpGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	4.17e-05	0.00114	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—RASGRP1—Crohn's disease	4.15e-05	0.00113	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	4.15e-05	0.00113	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—CXCL8—Crohn's disease	4.15e-05	0.00113	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—GPR65—Crohn's disease	4.11e-05	0.00112	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—IL3—Crohn's disease	4.1e-05	0.00112	CbGpPWpGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	4.09e-05	0.00112	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—GPR65—Crohn's disease	4.05e-05	0.00111	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—RASGRP1—Crohn's disease	4.04e-05	0.0011	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—IL3—Crohn's disease	4.03e-05	0.0011	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	4.02e-05	0.0011	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—RASGRP1—Crohn's disease	3.96e-05	0.00108	CbGpPWpGaD
Prochlorperazine—CHRM2—SIDS Susceptibility Pathways—IL6—Crohn's disease	3.95e-05	0.00108	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CCR6—Crohn's disease	3.9e-05	0.00107	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—RASGRP1—Crohn's disease	3.9e-05	0.00107	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—IL2RA—Crohn's disease	3.82e-05	0.00104	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—IL3—Crohn's disease	3.79e-05	0.00104	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—IL3—Crohn's disease	3.72e-05	0.00102	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—RASGRP1—Crohn's disease	3.66e-05	0.001	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—IL3—Crohn's disease	3.66e-05	0.001	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—RASGRP1—Crohn's disease	3.6e-05	0.000983	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—CXCL8—Crohn's disease	3.59e-05	0.000982	CbGpPWpGaD
Prochlorperazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	3.58e-05	0.000979	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—RASGRP1—Crohn's disease	3.54e-05	0.000968	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—RBX1—Crohn's disease	3.53e-05	0.000964	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—MTMR3—Crohn's disease	3.53e-05	0.000964	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—IL2RA—Crohn's disease	3.47e-05	0.000948	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PTGER4—Crohn's disease	3.43e-05	0.000938	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CCR6—Crohn's disease	3.38e-05	0.000924	CbGpPWpGaD
Prochlorperazine—DRD2—Circadian rythm related genes—IL6—Crohn's disease	3.34e-05	0.000912	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—IL2RA—Crohn's disease	3.31e-05	0.000905	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—CXCL8—Crohn's disease	3.17e-05	0.000867	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—CXCL8—Crohn's disease	3.11e-05	0.000851	CbGpPWpGaD
Prochlorperazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	3.1e-05	0.000848	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—UBE2D1—Crohn's disease	3.09e-05	0.000845	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—CXCL8—Crohn's disease	3.07e-05	0.000838	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—RBX1—Crohn's disease	3.06e-05	0.000836	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—IL2RA—Crohn's disease	3.01e-05	0.000822	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—RIPK2—Crohn's disease	3e-05	0.00082	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CCR6—Crohn's disease	2.98e-05	0.000816	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PTGER4—Crohn's disease	2.98e-05	0.000814	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CCR6—Crohn's disease	2.93e-05	0.000801	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IL3—Crohn's disease	2.92e-05	0.000799	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—IL2RA—Crohn's disease	2.92e-05	0.000799	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CCR6—Crohn's disease	2.88e-05	0.000788	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—IL2RA—Crohn's disease	2.87e-05	0.000784	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—RASGRP1—Crohn's disease	2.83e-05	0.000773	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—IL2RA—Crohn's disease	2.82e-05	0.000772	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—FADS1—Crohn's disease	2.75e-05	0.000751	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	2.71e-05	0.000741	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—RBX1—Crohn's disease	2.7e-05	0.000738	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—UBE2D1—Crohn's disease	2.68e-05	0.000733	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—IL2RA—Crohn's disease	2.65e-05	0.000725	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—RBX1—Crohn's disease	2.65e-05	0.000724	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PTGER4—Crohn's disease	2.63e-05	0.000718	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—RBX1—Crohn's disease	2.61e-05	0.000713	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—IL2RA—Crohn's disease	2.61e-05	0.000712	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—RIPK2—Crohn's disease	2.6e-05	0.000711	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PTGER4—Crohn's disease	2.58e-05	0.000705	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GPX4—Crohn's disease	2.57e-05	0.000703	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—JAK2—Crohn's disease	2.57e-05	0.000702	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—IL2RA—Crohn's disease	2.56e-05	0.000701	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—SOCS1—Crohn's disease	2.56e-05	0.0007	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PTGER4—Crohn's disease	2.54e-05	0.000694	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IL3—Crohn's disease	2.54e-05	0.000693	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GCKR—Crohn's disease	2.48e-05	0.000679	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—RASGRP1—Crohn's disease	2.45e-05	0.00067	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—TYK2—Crohn's disease	2.44e-05	0.000668	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—UBE2D1—Crohn's disease	2.37e-05	0.000647	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—CXCL8—Crohn's disease	2.34e-05	0.00064	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—JAK2—Crohn's disease	2.33e-05	0.000637	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—UBE2D1—Crohn's disease	2.32e-05	0.000635	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—MTMR3—Crohn's disease	2.31e-05	0.00063	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—RIPK2—Crohn's disease	2.3e-05	0.000627	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—UBE2D1—Crohn's disease	2.29e-05	0.000625	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—RIPK2—Crohn's disease	2.25e-05	0.000616	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IL3—Crohn's disease	2.24e-05	0.000612	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—JAK2—Crohn's disease	2.23e-05	0.000608	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—SOCS1—Crohn's disease	2.22e-05	0.000607	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—RIPK2—Crohn's disease	2.22e-05	0.000606	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—SMAD3—Crohn's disease	2.21e-05	0.000605	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IL3—Crohn's disease	2.2e-05	0.000601	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	2.16e-05	0.000592	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IL3—Crohn's disease	2.16e-05	0.000591	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—CXCL8—Crohn's disease	2.13e-05	0.000581	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—RASGRP1—Crohn's disease	2.13e-05	0.000581	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—TYK2—Crohn's disease	2.12e-05	0.000579	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—RASGRP1—Crohn's disease	2.09e-05	0.000572	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IL2RA—Crohn's disease	2.05e-05	0.00056	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—CXCL8—Crohn's disease	2.03e-05	0.000555	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—JAK2—Crohn's disease	2.02e-05	0.000552	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	1.96e-05	0.000537	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—SOCS1—Crohn's disease	1.96e-05	0.000536	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—JAK2—Crohn's disease	1.93e-05	0.000527	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—SOCS1—Crohn's disease	1.93e-05	0.000526	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	1.92e-05	0.000524	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—JAK2—Crohn's disease	1.9e-05	0.000519	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—SOCS1—Crohn's disease	1.89e-05	0.000518	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—TYK2—Crohn's disease	1.87e-05	0.000511	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	1.84e-05	0.000504	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—TYK2—Crohn's disease	1.84e-05	0.000502	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—TYK2—Crohn's disease	1.81e-05	0.000494	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—FADS1—Crohn's disease	1.8e-05	0.000491	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	1.79e-05	0.00049	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—JAK2—Crohn's disease	1.78e-05	0.000488	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	1.78e-05	0.000486	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—CXCL8—Crohn's disease	1.76e-05	0.000481	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—JAK2—Crohn's disease	1.75e-05	0.000479	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—CXCL8—Crohn's disease	1.73e-05	0.000473	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—JAK2—Crohn's disease	1.72e-05	0.000471	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—SMAD3—Crohn's disease	1.69e-05	0.000463	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GPX4—Crohn's disease	1.68e-05	0.00046	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—SMAD3—Crohn's disease	1.66e-05	0.000454	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—SMAD3—Crohn's disease	1.64e-05	0.000447	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	1.63e-05	0.000445	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GCKR—Crohn's disease	1.62e-05	0.000444	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—CXCL8—Crohn's disease	1.6e-05	0.000437	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—CXCL8—Crohn's disease	1.57e-05	0.00043	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IL2RA—Crohn's disease	1.57e-05	0.000428	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IL2RA—Crohn's disease	1.54e-05	0.000421	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IL2RA—Crohn's disease	1.51e-05	0.000414	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—TYK2—Crohn's disease	1.44e-05	0.000395	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—JAK2—Crohn's disease	1.38e-05	0.000376	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CXCL8—Crohn's disease	1.26e-05	0.000344	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TYK2—Crohn's disease	1.25e-05	0.000342	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—IL6—Crohn's disease	1.2e-05	0.000327	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—JAK2—Crohn's disease	1.19e-05	0.000326	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TYK2—Crohn's disease	1.1e-05	0.000302	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	1.09e-05	0.000298	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TYK2—Crohn's disease	1.08e-05	0.000296	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TYK2—Crohn's disease	1.07e-05	0.000292	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—JAK2—Crohn's disease	1.05e-05	0.000288	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—IL6—Crohn's disease	1.04e-05	0.000283	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—JAK2—Crohn's disease	1.03e-05	0.000283	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—JAK2—Crohn's disease	1.02e-05	0.000278	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—STAT3—Crohn's disease	1.01e-05	0.000276	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CXCL8—Crohn's disease	9.62e-06	0.000263	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CXCL8—Crohn's disease	9.44e-06	0.000258	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CXCL8—Crohn's disease	9.29e-06	0.000254	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—IL6—Crohn's disease	9.15e-06	0.00025	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—IL6—Crohn's disease	8.98e-06	0.000245	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—IL6—Crohn's disease	8.84e-06	0.000241	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—STAT3—Crohn's disease	8.76e-06	0.00024	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—ALB—Crohn's disease	7.91e-06	0.000216	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—STAT3—Crohn's disease	7.73e-06	0.000211	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—STAT3—Crohn's disease	7.59e-06	0.000208	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—STAT3—Crohn's disease	7.47e-06	0.000204	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IL6—Crohn's disease	7.06e-06	0.000193	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PTGS2—Crohn's disease	6.92e-06	0.000189	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IL6—Crohn's disease	6.12e-06	0.000167	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IL6—Crohn's disease	5.4e-06	0.000148	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IL6—Crohn's disease	5.3e-06	0.000145	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IL6—Crohn's disease	5.22e-06	0.000143	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ALB—Crohn's disease	5.17e-06	0.000141	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PTGS2—Crohn's disease	4.52e-06	0.000124	CbGpPWpGaD
